Section 1 Short title
This Act may be cited as the “Food and Drug Amendments of 2022”.
AN ACT
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.